When considering other tumour types in a pan-cancer analysis, LF2 was also associated with the EMT (P < 1.0 × 10−307) and FN1_TAM signatures (P < 1.0 × 10−307), as well as WT1 expression (P = 5.0 × 10−09) across tumour types, independent to ccRCC tumours (Table 2, Dataset EV5). The gene discussed is WT1; the disease is nonpapillary renal cell carcinoma.